company background image
ROG logo

Roche Holding SWX:ROG Stock Report

Last Price

CHF226.75

Market Cap

CHF182.2b

7D

-1.8%

1Y

-12.4%

Updated

27 Mar, 2024

Data

Company Financials +

ROG Stock Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania.

ROG fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends4/6

Roche Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Roche Holding
Historical stock prices
Current Share PriceCHF226.75
52 Week HighCHF293.55
52 Week LowCHF222.75
Beta0.15
1 Month Change-1.05%
3 Month Change-6.48%
1 Year Change-12.40%
3 Year Change-25.77%
5 Year Change-17.27%
Change since IPO768.77%

Recent News & Updates

Roche Holding's (VTX:ROG) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 06
Roche Holding's (VTX:ROG) Shareholders Will Receive A Bigger Dividend Than Last Year

Recent updates

Roche Holding's (VTX:ROG) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 06
Roche Holding's (VTX:ROG) Shareholders Will Receive A Bigger Dividend Than Last Year

Roche Holding's (VTX:ROG) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 09
Roche Holding's (VTX:ROG) Shareholders Will Receive A Bigger Dividend Than Last Year

Roche Holding's (VTX:ROG) Soft Earnings Are Actually Better Than They Appear

Feb 08
Roche Holding's (VTX:ROG) Soft Earnings Are Actually Better Than They Appear

Market Cool On Roche Holding AG's (VTX:ROG) Earnings

Dec 29
Market Cool On Roche Holding AG's (VTX:ROG) Earnings

We Think Roche Holding (VTX:ROG) Can Stay On Top Of Its Debt

Dec 07
We Think Roche Holding (VTX:ROG) Can Stay On Top Of Its Debt

Is Roche Holding (VTX:ROG) A Risky Investment?

Aug 27
Is Roche Holding (VTX:ROG) A Risky Investment?

Does Roche Holding (VTX:ROG) Have A Healthy Balance Sheet?

May 21
Does Roche Holding (VTX:ROG) Have A Healthy Balance Sheet?

Shareholder Returns

ROGCH PharmaceuticalsCH Market
7D-1.8%-0.1%0.8%
1Y-12.4%-4.5%3.3%

Return vs Industry: ROG underperformed the Swiss Pharmaceuticals industry which returned -4.5% over the past year.

Return vs Market: ROG underperformed the Swiss Market which returned 3.3% over the past year.

Price Volatility

Is ROG's price volatile compared to industry and market?
ROG volatility
ROG Average Weekly Movement2.9%
Pharmaceuticals Industry Average Movement3.1%
Market Average Movement3.4%
10% most volatile stocks in CH Market7.7%
10% least volatile stocks in CH Market1.8%

Stable Share Price: ROG has not had significant price volatility in the past 3 months.

Volatility Over Time: ROG's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1896103,605Thomas Schineckerhttps://www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas.

Roche Holding AG Fundamentals Summary

How do Roche Holding's earnings and revenue compare to its market cap?
ROG fundamental statistics
Market capCHF182.19b
Earnings (TTM)CHF11.50b
Revenue (TTM)CHF60.44b

15.7x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ROG income statement (TTM)
RevenueCHF60.44b
Cost of RevenueCHF15.60b
Gross ProfitCHF44.84b
Other ExpensesCHF33.35b
EarningsCHF11.50b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)14.42
Gross Margin74.19%
Net Profit Margin19.02%
Debt/Equity Ratio88.0%

How did ROG perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

67%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.